top of page

3 (Initial insider holdings report)

  • Apr 20
  • 3 min read

Title: 3 (Initial insider holdings report)   |   Filled Date: 2026-04-16   |   Entity Name: Hirschfeld Gideon - Intercure Ltd.


FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934


or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL


OMB Number: 3235-0104


Estimated average burden


hours per response: 0.5

1. Name and Address of Reporting Person*



Hirschfeld Gideon



(Last)    (First)    (Middle)



85 MEDINAT HA-YEHUDIM STREET



(Street)


HERZLIYA 4676670



(City)    (State)    (Zip)



ISRAEL


(Country)

2. Date of Event Requiring Statement


(Month/Day/Year)



03/18/2026

3. Issuer Name and Ticker or Trading Symbol



Intercure Ltd. [ INCR ]



3a. Foreign Trading Symbol

4. Relationship of Reporting Person(s) to Issuer


(Check all applicable)


X Director     10% Owner


Officer (give title below)     Other (specify below)

5. If Amendment, Date of Original Filed


(Month/Day/Year)

6. Individual or Joint/Group Filing


(Check Applicable Line)


X Form filed by One Reporting Person


  Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr. 4)

2. Amount of Securities Beneficially Owned (Instr. 4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)

4. Nature of Indirect Beneficial Ownership (Instr. 5)

 

 

 

 

Table II - Derivative Securities Beneficially Owned


(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)

2. Date Exercisable and Expiration Date (Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)

6. Nature of Indirect Beneficial Ownership (Instr. 5)


Date Exercisable

Expiration Date

Title

Amount or Number of Shares




Share options (right to buy)(1)

03/31/2020

01/09/2030

Ordinary Shares

4,046

$8.22

D


Share options (right to buy)(2)

09/30/2024

09/05/2028

Ordinary Shares

15,000

$3.1

D


Explanation of Responses:

1. The options were granted on January 9, 2020, and the current exercise price is NIS 25.146 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $8.22 per share. The options became fully vested as of January 9, 2023.

2. The options were granted on September 5, 2024, and the current exercise price is NIS 9.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $3.1 per share. The options vest on a quarterly basis over four years from the date of grant.

/s/ Gideon Hirschfeld    04/16/2026


** Signature of Reporting Person      Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

* Form 3: SEC 1473 (03-26)

 
 
bottom of page